Susquehanna International Group, LLP Ocular Therapeutix, Inc Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$4.2 - $8.69 $115,500 - $238,975	-27,500 Reduced 27.28%	73,300 $501,000
Q1 2024 May 07, 2024	BUY	$3.85 - $10.93 $106,645 - $302,761	27,700 Added 37.89%	100,800 $917,000
Q4 2023 Feb 14, 2024	SELL	$2.08 - $4.52 $51,792 - $112,547	-24,900 Reduced 25.41%	73,100 $326,000
Q3 2023 Nov 14, 2023	SELL	$3.14 - $5.04 $484,188 - $777,168	-154,200 Reduced 61.14%	98,000 $307,000
Q2 2023 Aug 11, 2023	SELL	$4.6 - $7.64 $38,640 - $64,176	-8,400 Reduced 3.22%	252,200 $1.3 Million
Q1 2023 May 16, 2023	BUY	$2.79 - $6.27 $496,062 - $1.11 Million	177,800 Added 214.73%	260,600 $1.37 Million
Q4 2022 Feb 14, 2023	SELL	$2.61 - $4.41 $328,077 - $554,337	-125,700 Reduced 60.29%	82,800 $232,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $539,471 - $857,350	131,900 Added 172.19%	208,500 $865,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $5.22 $148,995 - $258,390	-49,500 Reduced 39.25%	76,600 $308,000
Q1 2022 May 16, 2022	BUY	$4.83 - $7.35 $42,504 - $64,680	8,800 Added 7.5%	126,100 $624,000
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $824,824 - $1.62 Million	-133,900 Reduced 53.3%	117,300 $818,000
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $160,050 - $236,610	-16,500 Reduced 6.16%	251,200 $2.51 Million
Q2 2021 Aug 11, 2021	BUY	$13.43 - $19.16 $1.97 Million - $2.81 Million	146,600 Added 121.06%	267,700 $3.8 Million
Q1 2021 May 17, 2021	BUY	$15.82 - $22.11 $784,672 - $1.1 Million	49,600 Added 69.37%	121,100 $1.99 Million
Q4 2020 Feb 16, 2021	SELL	$7.91 - $22.95 $599,578 - $1.74 Million	-75,800 Reduced 51.46%	71,500 $1.48 Million
Q3 2020 Nov 16, 2020	SELL	$7.36 - $9.87 $520,352 - $697,809	-70,700 Reduced 32.43%	147,300 $1.12 Million
Q2 2020 Aug 14, 2020	SELL	$4.67 - $8.95 $96,669 - $185,264	-20,700 Reduced 8.67%	218,000 $1.82 Million
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $820,415 - $1.54 Million	207,700 Added 670.0%	238,700 $1.18 Million
Q3 2019 Nov 14, 2019	BUY	$3.04 - $5.32 $304 - $532	100 Added 0.32%	31,000 $94,000
Q2 2019 Aug 14, 2019	SELL	$2.46 - $4.52 $25,338 - $46,555	-10,300 Reduced 25.0%	30,900 $136,000
Q1 2019 May 15, 2019	SELL	$3.51 - $4.77 $252,017 - $342,485	-71,800 Reduced 63.54%	41,200 $164,000
Q4 2018 Feb 14, 2019	SELL	$3.87 - $7.11 $11,997 - $22,041	-3,100 Reduced 2.67%	113,000 $450,000
Q3 2018 Nov 14, 2018	BUY	$5.42 - $6.99 $63,414 - $81,783	11,700 Added 11.21%	116,100 $799,000
Q2 2018 Aug 14, 2018	SELL	$5.99 - $8.17 $162,928 - $222,224	-27,200 Reduced 20.67%	104,400 $705,000
Q1 2018 May 15, 2018	BUY	$4.66 - $7.08 $366,742 - $557,196	78,700 Added 148.77%	131,600 $857,000
Q4 2017 Feb 14, 2018	SELL	$3.73 - $6.37 $218,205 - $372,645	-58,500 Reduced 52.51%	52,900 $235,000
Q3 2017 Nov 14, 2017	BUY	$5.28 - $6.88 $588,192 - $766,432	111,400	111,400 $688,000

Others Institutions Holding OCUL

# of Institutions

151

Shares Held

136M

Call Options Held

86.4K

Put Options Held

263K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $668M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account